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10:00 AM–12:00 PM Pre-Congress Workshop
OARSI-FDA-INITIATIVE
Co-Chairs: Steven B. Abramson, MD
Marc C Hochberg, MD, MPH
Faculty: Robert Dworkin, PhD
Claim of Symptomatic Relief Working Group
Victor Goldberg, MD
Devices Working Group
David J. Hunter, MD, PhD
Assessment of Structural Change Working Group
Joanne Jordan, MD, MPH
Prevention Risk Reduction Working Group
Virginia Kraus, MD, PhD
Biomarkers Working Group
Nancy Lane, MD
Defining Disease State Working Group
10:00 AM – 12:00 PM Pre-Congress Workshop
OSTEOARTHRITIS INITIATIVE: ADVANCED TOPICS ON USE AND ANALYSIS OF
THE OAI PUBLIC DATA
10:00 am–10:30 am Research questions that can be addressed using OAI data: possibilities and limitations
Michael C. Nevitt, PhD
10:30 am–11:00 am OAI Online: access to clinical data, images and biospecimens, and data browsing tools
Susan M. Rubin, MPH
11:00 am–11:30 am OAI images and image-derived biomarkers
John Lynch, PhD
11:30 am–12:00 pm Longitudinal and hierarchical analytic strategies for OAI data
Charles McCulloch, PhD
Thursday, September 10, 2009
2:00 PM–2:10 PM WELCOME FROM PRESIDENT AND CONGRESS CO-CHAIRS
2:10 PM–3:30 PM Plenary Session 1 – Biomarkers
ROLE OF BIOMARKERS IN DIAGNOSIS AND MONITORING OF OA
2:10 PM–2:30 PM Clinical Perspective on the Role of Biomarkers and the Diagnosis and Monitoring of OA
Virginia Byers Kraus, MD, PhD
2:30 PM–2:50 PM Basic Science Perspective on the Role of Biomarkers in the Diagnosis and Monitoring
of OA
Dick Heinegard, MD, PhD
2:50 PM–3:00 PM Q & A
vi
Osteoarthritis and Cartilage Vol. 17, Supplement 1 vii
3:00 PM–3:15 PM 001 NOVEL BIOMARKERS OF KNEE OSTEOARTHRITIS IDENTIFIED USING METABOLIC
PROFILING p. S9
G. Zhai1, R. Wang-Sattler2, D. Hart1, T. Illig2, T.D. Spector1
1King’s Coll. London, London, United Kingdom; 2Inst. of Epidemiology, Neuherberg, Germany
3:15 PM–3:30 PM 002 IDENTIFICATION OF A NOVEL HTRA1-SUSCEPTIBLE CLEAVAGE SITE IN HUMAN
AGGRECAN: EVIDENCE FOR THE INVOLVEMENT OF HTRA1 IN AGGRECAN
PROTEOLYSIS IN VIVO p. S9
A. Chamberland, E. Wang, A.R. Jones, E.A. Morris, C.R. Flannery, Z. Yang
Wyeth Res., Cambridge, MA
4:00 PM–5:15 PM Plenary Session 2
INTRINSIC VS. EXTRINSIC CARTILAGE REPAIR
4:00 PM–4:30 PM Intrinsic Point of View
Ernst Hunziker, MD
4:30 PM–5:00 PM Extrinsic Point of View
Connie Chu, MD
5:00 PM–5:15 Pm Discussion
5:15 PM–5:45 PM Break
5:45 PM–6:15 PM OPENING CEREMONY /LIFETIME ACHIEVEMENT, BASIC AND CLINICAL AWARD PRESENTATIONS
6:15 PM–7:00 PM Keynote Lecture
AGING, INFLAMMATION AND OA
Martin Lotz, MD
7:00 PM–8:30 PM OPENING RECEPTION WITH EXHIBITORS
Friday, September 11, 2009
7:15 AM–8:45 AM Satellite Breakfast Symposium
SYNOVITIS: A POTENTIAL PREDICTOR OF OSTEOARTHRITIS PROGRESSION
Sponsored by Bioiberica
7:45 AM–8:45 AM Breakfast Workshop A
BIOMECHANICAL METHODS OF STUDYING JOINT FORCES
Thomas Brown, PhD
Breakfast Workshop B
IMMUNOHISTOCHEMISTRY & CONFOCAL TECHNIQUES
Claire Brown, PhD
9:00 AM–10:30 AM Plenary Session 3
HIGHEST RATED ABSTRACTS FROM YOUNG INVESTIGATORS
9:00 AM–9:15 AM 003 STRESS-DEPRIVATION UNCOUPLES METALLOPROTEINASE AND INHIBITOR
EXPRESSION AND REDUCES MATERIAL PROPERTIES OF DISTINCT TENDON REGIONS p. S10
J.L. Peterson1, M.M. Smith1, R.C. Appleyard2, C.B. Little1
1Raymond Purves Bone and Joint Res. Lab., The Kolling Inst. of Med. Res., Univ. of Sydney,
Royal North Shore Hosp., St Leonards, Australia; 2Murray Maxwell Biomechanics Lab., The
Kolling Inst. of Med. Res., Univ. of Sydney, Royal North Shore Hosp., St Leonards, Australia
viii Scientific Program
9:15 AM–9:30 AM 004 TILUDRONATE IN AN EXPERIMENTAL DOG MODEL OF OSTEOARTHRITIS: BONE
ANTI-RESORPTIVE ACTIVITY AND RELATED FUNCTIONAL IMPROVEMENT p. S10
M. Moreau1, P. Rialland1, J.-P. Pelletier2, J. Martel-Pelletier2, D. Lajeunesse2, C. Boileau2,
J. Caron2, G. Beauchamp1, D. Gauvin1, E. Troncy1
1GREPAQ - Fac. vet. med. - Université de Montréal, St-Hyacinthe, QC, Canada; 2Osteoarthritis
Res. Unit - Notre-Dame Hosp., CR-CHUM - Université de Montréal, Montréal, QC, Canada
9:30 AM–9:45 AM 005 USE OF A NOVEL IN VIVO KNEE JOINT LOADING MODEL TO DETERMINE THE
INTERPLAY BETWEEN GENETIC AND MECHANICAL FACTORS IN THE INITIATION AND
PROGRESSION OF MURINE OA p. S11
B. Poulet1, R.W. Hamilton2, P.D. Lee2, S.J. Shefelbine2, A.A. Pitsillides1
1The Royal Vet. Coll., London, United Kingdom; 2Imperial Coll. London, London, United Kingdom
9:45 AM–10:00 AM 006 BIOMECHANICAL MODELS EXPLAIN INCREASED RISKS FOR KNEE OSTEOARTHRITIS
DUE TO OBESITY AND LIMB ALIGNMENT p. S11
S. Lancianese, A. Lerner
Univ. of Rochester, Rochester, NY
10:00 AM–10:15 AM 007 MICRORNA-27b (miR-27b) REGULATES THE EXPRESSION OF MMP-13 IN HUMAN
OSTEOARTHRITIS CHONDROCYTES p. S12
N. Akhtar, Z. Rasheed, A.N. Anbazhagan, S. Ramamurthy, F.R. Voss, T.M. Haqqi
Univ. of South Carolina, Columbia, SC
10:15 AM–10:30 AM 008 NF-KAPPA B FAMILY MEMBER RELA/P65, A TRANSACTIVATOR OF SOX9, IS ESSENTIAL
FOR CHONDROGENIC DIFFERENTIATION AND SKELETAL GROWTH p. S12
S. Itoh, T. Saito, M. Ushita, T. Ikeda, F. Yano, N. Ogata, U.-i. Chung, K. Nakamura, H. Kawaguchi
Sensory & Motor System Med., Univ. of Tokyo, Tokyo, Japan
10:30 AM–11:00 AM OARSI BUSINESS MEETING
11:30 AM–12:30 PM Concurrent Session 1
BONE & OA
11:30 AM–12:00 PM The Role of Bone in the Progression and Development of OA
Daniel Lajeunesse, PhD
12:00 PM–12:15 PM 009 EARLY SUBCHONDRAL PLATE THINNING IN DIFFERENT EXPERIMENTAL CANINE
MODELS OF OA IS INTRINSIC TO CARTILAGE DEGENERATION WHILE TRABECULAR
CHANGES ARE RELATED TO UNLOADING p. S13
F. Intema1, S.C. Mastbergen1, J.W. Bijlsma1, H.A. Hazewinkel2, H.H. Weinans3, F.P. Lafeber1
1Rheumatology & Clin. Immunology UMC Utrecht, Utrecht, Netherlands; 2Faculty of Vet. Med.,
Univ. of Utrecht, Utrecht, Netherlands; 3Orthopaedics, ErasmusMC, Rotterdam, Netherlands
12:15 PM–12:30 PM 010 THE UNDERLYING MOLECULAR MECHANISMS OF PRIMARY HIP OSTEOARTHRITIS AND
ITS INVERSE RELATIONSHIP WITH FRACTURE COHORTS p. S13
D.D. Kumarasinghe1,2, B. Hopwood2,3, G.J. Atkins3,4, N.L. Fazzalari1,2
1Discipline of Pathology, Univ. of Adelaide, Adelaide, Australia; 2Bone & Joint Res. Lab, SA
Pathology, Adelaide, Australia; 3Hanson Inst., SA Pathology, Adelaide, Australia; 4Discipline of
Orthopaedics & Trauma, Univ. of Adelaide, Adelaide, Australia
11:30 AM–12:30 PM Concurrent Session 2
EPIDEMIOLOGY AND OA
11:30 AM–11:45 PM The Role of Epidemiology in Understanding OA
Jeffrey Katz, MD
11:45 AM–12:00 PM 011 TWO-YEAR INCIDENCE AND PREDICTORS OF FUTURE KNEE ARTHROPLASTY IN
PERSONS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS: PRELIMINARY ANALYSIS OF
LONGITUDINAL DATA FROM THE OSTEOARTHRITIS INITIATIVE p. S14
D.L. Riddle1, W.A. Jiranek1, X. Kong2
1Virginia Commonwealth Univ., Richmond, VA; 2Johns Hopkins Univ., Baltimore, MD
12:00 PM–12:15 PM 012 RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS DOES NOT VARY BY KNEE
EXTENSOR STRENGTH AND KNEE JOINT POSITION SENSE p. S15
N.A. Segal1, N.A. Glass1, D. Felson2, M. Hurley3, M. Yang2, M. Nevitt4, C.E. Lewis5,
J.C. Torner1
Osteoarthritis and Cartilage Vol. 17, Supplement 1 ix
1Univ. of Iowa, Iowa City, IA; 2Boston Univ., Boston, MA; 3King’s Coll. London, London, United
Kingdom; 4Univ. of California at San Francisco, San Francisco, CA; 5Univ. of Alabama at
Birmingham, Birmingham, AL
12:15 PM–12:30 PM 013 IMPAIRMENT OF FUNCTION IS THE MAJOR DETERMINANT OF REDUCED
HEALTH-RELATED QUALITY OF LIFE IN HAND OSTEOARTHRITIS PATIENTS IN
SECONDARY CARE p. S16
W.Y. Kwok, T.P. Vliet Vlieland, M. Kloppenburg, T.W. Huizinga
Leiden Univ. Med. Ctr., Leiden, Netherlands
12:30 PM–2:00 PM Satellite Lunch Symposium
SYMPTOMATIC TREATMENT AND STRUCTURE MODIFICATION IN OA: NOW THE
EVIDENCE
Sponsored by IBSA
2:00 PM–3:30 PM Concurrent Session 3
INNATE IMMUNITY & OA
2:00 PM–2:30 PM Innate Immune System Activation in OA: is OA a Chronic Wound?
Carla Scanzello, MD, PhD
2:30 PM–2:45 PM 014 THE ASSOCIATIONS BETWEEN LEPTIN, INTERLEUKIN 6 AND HIP RADIOGRAPHIC
OSTEOARTHRITIS IN OLDER PEOPLE p. S16
C. Ding1,2, O. Stannus1, F. Cicuttini2, D. Dore1, G. Jones1
1Univ. of Tasmania, Hobart, Australia; 2Monash Univ., Melbourne, Australia
2:45 PM–3:00 PM 015 COMPARISON OF THE EXPRESSION PROFILES OF SYNOVIAL TISSUE INFLAMMATION
BETWEEN END-STAGE AND PROGRESSIVE KNEE OSTEOARTHRITIS p. S17
N. Liang1, H. Kaneko1, M. Ishijima1, M. Kubota1, I. Futami1, L. Zu1, T. Kawasaki1, Y. Takazawa1,
H. Ikeda1, H. Kurihara2, E. Arikawa-Hirasawa3, H. Kurosawa1
1Dept of Orthopaedics, Juntendo Univ., Tokyo, Japan; 2Dept of Anatomy and Life Structure,
Juntendo Univ., Tokyo, Japan; 3Res. Inst. for Diseases of Old Ages, Juntendo Graduate Sch. of
Med., Tokyo, Japan
3:00 PM–3:15 PM 016 IL-1 SIGNALS BEYOND THE CANONICAL PATHWAY IN MURINE OA p. S17
S.S. Glasson, A.R. Jones, M.A. Rivera-Bermudez, T. Blanchet, E.A. Morris
Wyeth, Cambridge, MA
3:15 PM–3:30 PM 017 INHIBITORY INTERACTIONS BETWEEN HMGB1 AND HEME OXYGENASE-1 PATHWAYS IN
OSTEOARTHRITIC SYNOVIOCYTES p. S18
I. García-Arnandis1, I. Guillén1,2, M.A. Castejón3, M. Alcaraz1
1Univ. of Valencia, Dept. Pharmacology, Burjasot, Spain; 2Cardenal Herrera-CEU Univ.,
Moncada, Spain; 3La Ribera Univ. Hosp., Alzira, Spain
2:00 PM–3:30 PM Concurrent Session 4
MEASUREMENT OF OUTCOMES IN OA THERAPY
2:00 PM–2:30 PM New Approaches to Measurement of Outcomes to Assess Efficacy of OA Treatment
Maxime Dougados, MD
2:30 PM–2:45 PM 018 RELATIONSHIP OF WEIGHT CHANGE WITH CHANGE IN KNEE PAIN AND FUNCTION IN
PERSONS WITH SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS: ONE-YEAR
FOLLOW-UP DATA FROM THE OSTEOARTHRITIS INITIATIVE p. S18
M.C. Hochberg1, K. Favors1, D. Bujak1, T. Niculescu1, S. Bartlett2, J. Bathon2, J. Sorkin1
1Univ. of Maryland, Baltimore, MD; 2The Johns Hopkins Univ., Baltimore, MD
2:45 PM–3:00 PM 019 THE EFFECT OF LONG-TERM VIGOROUS PHYSICAL ACTIVITY ON KNEE CARTILAGE
AMONG ADULTS WITHOUT CLINICAL KNEE DISEASE p. S19
A.J. Teichtahl1, A.E. Wluka1, Y. Wang1, A. Forbes1, M.L. Davies-Tuck1, D.R. English2,3,
G.G. Giles3, F.M. Cicuttini1
1Dept. of Epidemiology and Preventive Med., Sch. of Publ. Hlth.and Preventive Med.,
Monash Univ., Melbourne, Australia; 2Ctr. for Molecular, Environmental, Genetic and Analytic
Epidemiology, Sch. of Population Hlth., Univ. of Melbourne, Melbourne, Australia; 3Cancer
Epidemiology Ctr., The Cancer Council Victoria, Melbourne, Australia
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3:00 PM–3:15 PM 020 DETERMINANTS OF LONG-TERM RADIOGRAPHIC AND CLINICAL PROGRESSION OF
HAND OSTEOARTHRITIS p. S19
J. Bijsterbosch, I. Watt, I. Meulenbelt, F.R. Rosendaal, T.W. Huizinga, M. Kloppenburg
Leiden Univ. Med. Ctr., Leiden, Netherlands
3:15 PM–3:30 PM 021 PAIN IMPROVEMENTS FOLLOWING TOTAL JOINT REPLACEMENT: WHAT YOU MEASURE
MATTERS p. S19
A.M. Davis1, L.S. Lohmander2, R. Wong1, V. Venkataramanan1, G.A. Hawker3
1Toronto Western Res. Inst., Toronto, ON, Canada; 2Univ. Hosp. in Lund, Lund, Sweden;
3Women’s Coll. Hosp., Toronto, ON, Canada
3:30 PM–5:00 PM POSTER SESSION 1
Including Moderated Poster Session – Presentations by Young Investigators / Students
5:00 PM–6:30 PM Concurrent Session 5
GENETICS/EPIGENETICS AND CARTILAGE DEGENERATION
5:00 PM–5:30 PM Advances in Understanding the Role of Genetics in OA
Ele Zeggini, PhD
5:30 PM–6:00 PM Epigenetics and Cartilage Degeneration Helmtrud Roach, PhD
6:00 PM–6:15 PM 022 FOLLOW-UP ANALYSIS OF THE ROLE OF GENETIC VARIATION IN ADAMTS14 IN
OSTEOARTHRITIS SUSCEPTIBILITY p. S20
A. Gonzalez1, C. Rodriguez-Fontela1, M. Calaza1, A. Carr2, M. Doherty3, J.J. Gomez-Reino1,4,
J. Loughlin5, T. Spector6, A. Tsezou7, A.M. Valdes6
1Hosp. Clinico Univ.rio de Santiago, Santiago de Compostela, Spain; 2Nuffield Orthopaedic
Ctr., Oxford, United Kingdom; 3Univ. of Nothingham, Nottingham, United Kingdom; 4Univ. of
Santiago de Compostela, Santiago de Compostela, Spain; 5Newcastle Univ., Newcastle upon
Tyne, United Kingdom; 6St. Thomas Hosp. Campus, Kings Coll., London Sch. of Med., London,
United Kingdom; 7Univ. of Thessaly, Larissa, Greece
6:15 PM–6:30 PM 023 META-ANALYSIS OF GENOME-WIDE ASSOCIATION STUDIES OF OSTEOARTHRITIS p. S21
E. Evangelou1, A.M. Valdes2, U. Styrkársdóttir3, H. Kerkhof4, I. Jonsdottir3, A. Uitterlinden4,
Y. Zhu5, A. Cupples6, J.P. Ioannidis1, K. Stefanson3, D. Felson5, J. Van Meurs4, T.D. Spector2
1Dept. of Hygiene and Epidemiology, Univ. of Ioannina, Ioannina, Greece; 2King’s Coll. London,
London, United Kingdom; 3deCODE genetics, Reykjavik, Iceland; 4Dept. of Epidemiology,
Erasmus Med. Ctr., Rotterdam, Netherlands; 5Boston Univ. Sch. of Med., Boston, MA; 6Boston
Univ. Sch. of Publ. Hlth., Boston, MA
5:00 PM–6:30 PM Concurrent Session 6
MUSCLE STRENGTH, PROPRIOCEPTION & OA
5:00 PM–5:30 PM Advances in Understanding the Role of Muscle Strength and Proprioception in the
Development and Progression of OA
Neil Segal, MD
5:30 PM–5:45 PM 024 EXERCISE OR NOT TO EXERCISE: A GENOME WIDE ANALYSIS OF EFFECTS OF
EXERCISE ON EARLY AND LATE OA p. S21
P. Perera, J. Nam, J. Friezner, S. Agarwal
The Ohio State Univ., Columbus, OH
5:45 PM–6:00 PM 025 GAMMA-LOOP DYSFUNCTION CONTRIBUTES TO QUADRICEPS INHIBITION IN PATIENTS
WITH KNEE JOINT OSTEOARTHRITIS p. S22
D. Rice, P.J. McNair, G. Lewis
Auckland Univ. of Technology, Auckland, New Zealand
6:00 PM–6:15 PM 026 PAIN, FUNCTION AND MUSCLE STRENGTH IN MENISCECTOMIZED PATIENTS AT HIGH
RISK OF OA COMPARED TO AGE- AND GENDER MATCHED CONTROLS p. S22
J.B. Thorlund, P. Aagaard, E.M. Roos
Inst. of Sports Sci. and Clinical Biomechanics, Univ. of Southern Denmark, Odense M, Denmark
6:15 PM–6:30 PM 027 KNEE STRENGTH PREDICTS LOSS OF FUNCTION AND DECLINE IN PHYSICAL ACTIVITY
IN PARTICIPANTS WITH OSTEOARTHRITIS: A 2-YR FOLLOW-UP OF THE OAI STUDY p. S23
F. Haq, M. Gurcan, K. Powell, R.D. Jackson, J. Prescott, M. Swanson, T.M. Best
Ohio State Univ. Med. Ctr., Columbus, OH
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7:45 AM–8:45 AM Breakfast Workshop C
DESIGNING AN OA CLINICAL TRIAL
Jean-Pierre Pelletier, MD
7:45 AM–8:45 AM Breakfast Workshop D
HOW TO USE MESENCHYMAL STEM CELLS IN OA RESEARCH
Christian Jorgensen, MD
9:00 AM–10:30 AM Concurrent Session 7
CLINICAL IMPLICATIONS OF MODERN IMAGING TECHNOLOGIES
9:00 AM–9:30 AM Strategies to Use Modern Imaging Technologies to Evaluate Patients with OA
Flavia Cicuttini, MD, MBBS
9:30 AM–9:45 AM 028 OPTICAL COHERENCE TOMOGRAPHY (OCT) AND QUANTITATIVE MRI SHOW EARLY
SUBSURFACE MATRIX DEGENERATION IN HUMAN ARTICULAR CARTILAGE p. S23
D.M. Bear, A. Williams, Y. Qian, C.R. Chu
Univ. of Pittsburgh, Pittsburgh, PA
9:45 AM–10:00 AM 029 TEMPORAL STRUCTURAL CHANGES IN HIP OA DETECTED BY SHAPE AND
APPEARANCE MODELLING OF DXA IMAGES: A ONE-YEAR PROSPECTIVE
LONGITUDINAL STUDY p. S24
K. Yoshida1, J.S. Gregory1, R.J. Barr1, S. Alesci2, R.M. Aspden1, D.M. Reid1
1Univ. of Aberdeen, Aberdeen, United Kingdom; 2Discovery Translational Med., Wyeth Res.,
Collegeville, PA
10:00 AM–10:15 AM 030 RADIAL MRI AND 3D dGEMRIC IN DEVELOPMENTAL DYSPLASIA OF THE HIP AND IN
FEMOROACETABULAR IMPINGEMENT p. S24
S.E. Domayer1, I. Kress1, J. Chan1, T.C. Mamisch2, Y.-J. Kim1
1Children’ s Hosp. Boston, Boston, MA; 2Dept. of Orthopedics, Bern, Switzerland
10:15 AM–10:30 AM 031 RELATIONSHIP BETWEEN MENISCUS VOLUME AND CARTILAGE MORPHOLOGY IN MR
IMAGES OF OSTEOARTHRITIS PATIENTS p. S25
J.W. Prescott, M.S. Swanson, K. Hoang, M. Pennell, F. Haq, T.M. Best, R.D. Jackson,
M.N. Gurcan
Ohio State Univ., Columbus, OH
9:00 AM–10:30 AM Concurrent Session 8
AGING OF CELLS & MATRIX
9:00 AM–9:30 AM Advances in the Understanding of the Role of Aging in the Development and Progression
of OA
Jochen Haag, PhD
9:30 AM–9:45 AM 032 A REDUCTION IN SIRT1 LEVELS IN OA ARTICULAR CARTILAGE IS ASSOCIATED WITH
AN INCREASE IN PTP1B, MMP13 AND CHONDROCYTE APOPTOSIS p. S26
O. Gabay, V. Gagarina, E. Lee, M. Dvir-Ginzberg, J. Onodera, D. Hall Sr
NIH, Bethesda, MD
9:45 AM–10:00 AM 033 OXIDIZED LDL INDUCES STRESS-INDUCED PREMATURE SENESCENCE IN CULTURED
BOVINE ARTICULAR CHONDROCYTES p. S26
M. Akagi, S. Zushi, H. Kishimoto, T. Teramura, S. Nishimura, C. Hamanishi
Kinki Univ. Sch. of Med., Osaka-Sayama City, Japan
10:00 AM–10:15 AM 034 REDUCTION IN ARTICULAR CARTILAGE LESIONS IN OLDER ADULT MICE
OVEREXPRESSING CATALASE TARGETED TO MITOCHONDRIA p. S27
R.F. Loeser1, M.A. McNulty2, P.M. Treuting3, C.S. Carlson2
1Wake Forest Univ. Sch. of Med., Winston Salem, NC; 2Univ. of Minnesota Coll. of Vet. Sci., St.
Paul, MN; 3Univ. of Washington, Seattle, WA
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10:15 AM–10:30 AM 035 EFFECTS OF INORGANIC PYROPHOSPHATE ON CHONDROCYTE RESPONSE WHEN
ENCAPSULATED IN 3D SYNTHETIC HYDROGELS p. S27
N. Bishop1, M. Kissler1, M. Husa2, R. Terkeltaub2, S. Bryant1
1Univ. of Colorado, Boulder, CO; 2VA Med. Ctr. San Diego, San Diego, CA
11:00 AM–12:30 PM Concurrent Session 9
PAIN TARGETS IN OA
11:00 AM–11:30 AM New Strategies for Treating Pain in Patients with OA
Richard Leff, MD
11:30 AM–11:45 PM 036 DEVELOPMENT OF RADIOLOGICAL OSTEOARTHRITIS PATHOLOGY AT FOLLOW-UP IN
PEOPLE WITH JOINT PAIN AT BASELINE p. S28
B.M. de Klerk, D. Schiphof, B.W. Koes, S.M. Bierma-Zeinstra
Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
11:45 AM–12:00 PM 037 A TOOL THAT IDENTIFIES NEUROPATHIC PAIN SYMPTOMS IN A COMMUNITY KNEE OA
COHORT p. S28
J. Hochman1,2, D. Sutton1, M. French1, L. Gagliese3, A. Davis4, G. Hawker1,2
1Women’s Coll. Hosp., Toronto, ON, Canada; 2Univ. of Toronto, Toronto, ON, Canada; 3Univ.
Hlth.Network, Toronto, ON, Canada; 4Toronto Western Res. Inst., Toronto, ON, Canada
12:00 PM–12:15 PM 038 PERIPHERAL EFFECTS OF ENDOGENOUS LIGANDS IN THE RAT INFLAMED JOINT
MODEL p. S29
L. Mécs, K. Tóth, K. Wellinger, G. Tuboly, G. Kékesi, G. Horváth
Univ. of Szeged, Szeged, Hungary
12:15 AM–12:30 PM 039 VALIDITY OF PAIN ASSESSMENT METHODS IN THE EXPERIMENTAL DOG POND-NUKI
MODEL p. S29
P. Rialland1, M. Moreau1, J.-P. Pelletier2, J. Martel-Pelletier2, D. Lajeunesse2, C. Boileau2,
J. Caron2, G. Beauchamp1, D. Gauvin1, E. Troncy1
1GREPAQ - Fac. vet. med. - Université de Montréal, St-Hyacinthe, QC, Canada; 2Osteoarthritis
Res. Unit - Notre-Dame Hosp., CR-CHUM - Université de Montréal, Montréal, QC, Canada
11:00 AM–12:30 PM Concurrent Session 10
DEBATE: DIFFERENT OA PHENOTYPES
11:00 AM–11:25 PM Basic Science Studies of OA Phenotypes: Their Role in Understanding the Development
and Progression of OA
Steven Abramson, MD
11:25 AM–11:50 PM Distinct Clinical Phenotypes of OA
Wolfgang Ruether, MD
11:50 AM–12:15 PM Identifying Different OA Phenotypes Through Epidemiologic Research
David Felson, MD, MPH
12:15 PM–12:30 PM 15 minute DISCUSSION
12:30 PM–1:30 PM Educational Workshop for Young Investigators
HOW TO PRESENT A TALK: GUIDANCE FOR THE NEW INVESTIGATOR
Linda Sandell, PhD
12:45 PM–2:15 PM Satellite Lunch Symposium
NEW PARADIGMS IN THE TREATMENT OF OSTEOARTHRITIS PATIENTS WITH
HYPERTENSION
Sponsored by NicOx
2:15 PM–3:30 PM Concurrent Session 11
SURGICAL METHODS OF STIMULATING RESTORATION OF JOINT SURFACES:
OSTEOTOMIES AND JOINT DISTRACTION
2:15 PM–2:30 PM Surgical Methods of Restoring an Articular Surface in Osteoarthritic Joints
Bert Mandelbaum, MD
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2:30 PM–2:45 PM Use of Animal Models to Develop Surgical Methods of Stimulating Restoration of Joint
Surfaces in Osteoarthritic Joints
Floris Lafeber, PhD
2:45 PM–3:00 PM 040 INJECTION OF ALLOGENEIC IMMUNOSELECTED STRO-3+ MESENCHYMAL PRECURSOR
STEM CELLS INTO LUMBAR INTERVERTEBRAL DISCS ATTENUATES DEGENERATION
AND PROMOTES THE RESTORATION OF THE DISC EXTRACELLULAR MATRIX. AN
EXPERIMENTAL STUDY IN AN OVINE MODEL OF DISC DEGENERATION p. S30
P. Ghosh1, S. Itescu1, R. Moore2, B. Vernon-Roberts2, T. Goldschlager3, A. Zannettino2,
S. Gronthos2, C. Little4, C. Shu4, J. Melrose4
1Mesoblast Ltd, Melbourne, Australia; 2Inst. of Vet. and Med. Sci., Adelaide, Australia; 3Monash
Univ., Melbourne, Australia; 4Univ. of Sydney, Sydney, Australia
3:00 PM–3:15 PM 041 CARTILAGE RESTORATION AFTER HIGH TIBIAL OSTEOTOMY p. S30
G. Spahn1, G.O. Hofmann2
1Ctr. of Traumatology and Orthopaedic Surgery, Eisenach, Germany; 2Ctr. of Trauma Univ. of
Jena and Trauma Ctr. Halle, Jena and Halle, Germany
3:15 PM–3:30 PM 042 SUBCHONDRAL BONE DENSITY CHANGES MAY PARTLY EXPLAIN THE CLINICAL
BENEFIT OF JOINT DISTRACTION IN TREATMENT OF ADVANCED ANKLE OA p. S31
F. Intema1, T.P. Thomas2, D.D. Anderson2, J.M. Elkins2, F.P. Lafeber1, T.D. Brown2,
A. Amendola2, C.L. Saltzman3
1Rheumatology & Clin. Immunology, UMC Utrecht, Utrecht, Netherlands; 2The Univ. of Iowa,
Iowa City, IA; 3The Univ. of Utah, Salt Lake City, UT
2:15 PM–3:30 PM Concurrent Session 12
INFLAMMATION AND OA: THE ROLE OF ADIPOKINES
2:15 PM–2:45 PM Understanding the Role of Inflammation in OA
Francis Berenbaum, MD, PhD
2:45 PM–3:00 PM 043 IN VIVO EVIDENCE OF THE IMPLICATION OF PROTEINASE-ACTIVATED RECEPTOR
(PAR)-2 IN CARTILAGE DEGRADATION IN A MOUSE MODEL OF OSTEOARTHRITIS p. S32
N. Amiable1, J. Martel-Pelletier1, J.-P. Pelletier1, B. Lussier2, F. Paré1, S. Tremblay1, C. Boileau1
1Osteoarthritis Res. Unit, Notre-Dame Hosp., Univ. of Montreal Hosp. Res. Ctr. (CRCHUM),
Montreal, QC, Canada; 2Dept. of Vet. Med., Clinical Sci., Univ. of Montreal, St-Hyacinthe, QC,
Canada
3:00 PM–3:15 PM 044 EFFICACY OF CHONDROTIN SULPHATE ON SYNOVITIS IN PATIENTS WITH KNEE
OSTEOARTHRITIS: AN ULTRASOUND STUDY p. S32
I. Möller
Inst. Poal de Reumatología, Barcelona, Spain
3:15 PM–3:30 PM 045 SERUM LEVELS OF INFLAMMATORY MARKERS, KNEE RADIOGRAPHIC
OSTEOARTHRITIS, AND KNEE CARTILAGE LOSS IN OLDER ADULTS p. S33
C. Ding1,2, F. Cicuttini3, V. Parameswaran4, O. Stannus1, J. Burgess1, G. Jones1
1Univ. of Tasmania, Hobart, Australia; 2Monash Univ., Melbourne, Australia; 3Monosh Univ.,
Melbourne, Australia; 4Royal Hobart Hosp., Hobart, Australia
3:30 PM–5:00 PM POSTER SESSION 2
5:00 PM–6:00 PM Concurrent Session 13
BIO PSYCHOSOCIAL ASPECTS IN OA
5:00 PM–5:20 PM Coping with Arthritis Pain: Current Trends and Future Directions
Francis Keefe, PhD
5:20 PM–5:40 PM Sleep and Pain Interaction: A Circular Problem?
Gilles Lavigne, PhD, DMD
5:45 PM–6:00 PM 046 RACIAL DIFFERENCES IN OSTEOARTHRITIS PAIN AND FUNCTION: POTENTIAL
EXPLANATORY FACTORS p. S33
K.D. Allen1,2, E.Z. Oddone1,2, C.J. Coffman1,2, F.J. Keefe2, J.H. Lindquist1, H.B. Bosworth1,2
1Durham VA Med. Ctr., Durham, NC; 2Duke Univ. Med. Ctr., Durham, NC
xiv Scientific Program
5:00 PM–6:00 PM Concurrent Session 14
CELL MATRIX INTERACTIONS
5:00 PM–5:30 PM Update on Matrix Degradation: Role of Matrix Degradation in OA
Chris B. Little, PhD, BVMS
5:30 PM–5:45 PM 047 DIFFERENTIAL REGULATION OF THE INSULIN-LIKE GROWTH FACTOR BINDING
PROTEIN-5 AND MATRIX METALLOPROTEASE-13 GENES BY THE MICRORNAS MIR-140
AND MIR-27A IN HUMAN OSTEOARTHRITIC CHONDROCYTES p. S33
G. Tardif1, D. Hum1, J.-P. Pelletier1, N. Duval2, J. Martel-Pelletier1
1Osteoarthritis Res. Unit, Notre-Dame Hosp., Univ. of Montreal Hosp. Res. Ctr. (CRCHUM),
Montreal, QC, Canada; 2Duval Clinique Orthopédique, Le Pavillon des Charmilles, Laval, QC,
Canada
5:45 PM–6:00 PM 048 EVIDENCE FOR A ROLE OF DICKOPPF-3 IN THE PATHOGENESIS OF OSTEOARTHRITIS p. S34
S. Snelling1, R.K. Davidson2, T.E. Swingler2, I. Clark2
1Univ. of Oxford, Oxford, United Kingdom; 2Univ. of East Anglia, Norwich, United Kingdom
7:00 PM–10:00 PM CONGRESS DINNER
Sunday , September 13, 2009
7:45 AM–8:45 AM Breakfast Workshop E
CLINICAL APPLICATIONS OF GAIT ANALYSIS
Monica Maly, PT, PhD
7:45 AM–8:45 AM Breakfast Workshop F
ANIMAL HISTOPATHOLOGY
Dog – Keiichi Kuroki, DVM, PhD
Rat – Nicole Gerwin, PhD
9:00 AM–10:30 AM Concurrent Session 15
POST-TRAUMATIC OA
9:00 AM–9:30 AM New Understanding of the Role of Joint Injury in the Development of OA
Martin Lotz, MD
9:30 AM–9:45 AM 049 JOINT INJURY LEADS TO SIGNIFICANTLY INCREASED AGGRECANASE ACTIVITY IN
HUMANS AND PRECLINICAL ANIMAL MODELS p. S34
P.S. Chockalingam1, W. Sun1, M. Rivera-Bermudez1, S. Glasson1, J. Lee1, S. Larsson2,
L.S. Lohmander2, K.E. Georgiadis1, E.A. Morris1
1Wyeth Res., Cambridge, MA; 2Dept. of Orthopedics, Clinical Sci. Lund, Lund University, Sweden
9:45 AM–10:00 AM 050 COMP IN POSTTRAUMATIC OA p. S35
E. Lindhorst1, R. Raiss2, A. Theisen2, F. Hentschel2, T. Aigner3, L. Wachsmuth4
1Univ. of Bochum, Univ. of Marburg, Univ. of Frankfurt/Main, Bochum, Germany; 2Univ. of
Frankfurt/Main, Frankfurt/Main, Germany; 3Univ. of Leipzig, Univ. of Erlangen, Leipzig, Germany;
4Univ. of Erlangen, Erlangen, Germany
10:00 AM–10:15 AM 051 PREVALENCE AND INCIDENCE OF POST-TRAUMATIC OSTEOARTHRITIS IN THE
POPULATION OF THE PROVINCE OF QUEBEC p. S35
J. Vaillancourt, J. Sampalis
McGill Univ. and JSS Med. Res., Montreal, QC, Canada
10:15 AM–10:30 AM 052 OPTICAL COHERENCE TOMOGRAPHY (OCT) SIGNAL CHANGES ARE POTENTIAL
BIOMARKERS OF ACUTE CARTILAGE INJURY p. S36
D.M. Bear, M. Szczodry, S. Kramer, P. Smolinski, C.R. Chu
Univ. of Pittsburgh, Pittsburgh, PA
Osteoarthritis and Cartilage Vol. 17, Supplement 1 xv
9:00 AM–10:30 AM Concurrent Session 16
TARGETING SIGNALING PATHWAYS
9:00 AM–9:30 AM Targeting Signaling Pathways in Developing New Treatments for OA
Frank Beier, PhD
9:30 AM–9:45 AM 053 REACTIVE OXYGEN SPECIES INHIBIT IGF-I INDUCTION OF CHONDROCYTE
PROTEOGLYCAN SYNTHESIS THROUGH DIFFERENTIAL REGULATION OF PI-3
KINASE-AKT AND MEK-ERK MAPK SIGNALING PATHWAYS p. S36
R.F. Loeser, W. Yin
Wake Forest Univ. Sch. of Med., Winston Salem, NC
9:45 AM–10:00 AM 054 EXTRACELLULAR SULFATASES SUPPORT CARTILAGE HOMEOSTASIS BY REGULATING
BMP AND FGF SIGNALING PATHWAYS p. S37
S. Otsuki1, S. Miyaki1, S.P. Grogan1, H. Asahara1, M. Kinoshita2, M.K. Lotz1
1The Scripps Res. Inst., La Jolla, CA; 2Osaka Med. Coll., Osaka, Japan
10:00 AM–10:15 AM 055 HYPOXIA CONDITIONS DIFFERENTIALLY MODULATE NORMAL AND OSTEOARTHRITIC
HUMAN ARTICULAR CHONDROCYTE PROTEOMES p. S37
V. Carreira, C. Ruiz-Romero, J. Mateos, V. Calamia, B. Cillero-Pastor, P. Fernandez-Puente,
F. Galdo, F.J. Blanco
Osteoarticular and Aging Res. Lab. Proteomics Unit Associated Node to ProteoRed,
INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain
10:15 AM–10:30 AM 056 ALTERED WNT/b-CATENIN SIGNALING IN HUMAN OSTEOARTHRITIC SUBCHONDRAL
OSTEOBLASTS IS DUE TO DICKKOPF-2 (DKK2) AND PROSTAGLANDIN E2 (PGE2)
LEVELS p. S38
T.F. Chan, D. Couchourel, A. Delalandre, D. Lajeunesse
CRCHUM, Hôpital Notre-Dame, Montréal, QC, Canada
10:45 AM–12:15 AM Plenary Session 4
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